Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Uwe Krueger is active.

Publication


Featured researches published by Uwe Krueger.


Journal of Medicinal Chemistry | 1992

(H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.

Bernhard Kohl; Ernst Sturm; Joerg Senn-Bilfinger; W. Alexander Simon; Uwe Krueger; Hartmann Schaefer; Georg Rainer; Volker Figala; Kurt Klemm


Journal of Organic Chemistry | 1987

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiols

Joerg Senn-Bilfinger; Uwe Krueger; Ernst Sturm; Volker Figala; Kurt Klemm; Bernhard Kohl; Georg Rainer; Hartmann Schaefer; Timothy J. Blake


Journal of Organic Chemistry | 1987

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 1. Their reaction with thiols under acidic conditions. Disulfide containing 2-pyridiniobenzimidazolides as mimics for the inhibited enzyme

Ernst Sturm; Uwe Krueger; Joerg Senn-Bilfinger; Volker Figala; Kurt Klemm; Bernhard Kohl; Georg Rainer; Hartmann Schaefer; Timothy J. Blake


Journal of Organic Chemistry | 1990

(H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 3. Evidence for the involvement of a sulfenic acid in their reactions

Uwe Krueger; Joerg Senn-Bilfinger; Ernst Sturm; Volker Figala; Kurt Klemm; Bernhard Kohl; Georg Rainer; Hartmann Schaefer; Timothy J. Blake


Archive | 2005

ANALOGOS PEPTIDICOS SINTETICOS DA PROTEINA SURFACTANTE PULMONAR SP-C

Hafner Dietrich; Ulrich Wolf-Rudiger; Ruediger Nave; Ernst Sturm; Uwe Krueger; Schaefer Klaus P; Klaus Melchers


Archive | 1998

Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten Benzamide and contain pulmonary surfactant compositions for the treatment of IRDS or ARDS, the 3- (cyclopropylmethoxy) -N- (3,5-dichloro-4-pyridinyl) -4- (difluoromethoxy)

Paul-Georg Germann; Ulrich Kilian; Rolf Beume; Hermann Amschler; Uwe Krueger; Dietrich Haefner; Klaus Eistetter


Archive | 1998

Compositions for the treatment of IRDS or ARDS 3- (calcopropylmethoxy) -N- contain (3,5-dichloro-4-pyridinyl) -4- (difluoromethoxy) benzamide and lung surfactant

Paul-Georg Germann; Ulrich Kilian; Rolf Beume; Hermann Amschler; Uwe Krueger; Dietrich Haefner; Klaus Eistetter


Archive | 1997

Use of N-(3,5-dichloropyrid-4-yl)-3-cyclopropymethoxy-4- difluoromethoxybenzamide

Dietrich Haefner; Paul-Georg Germann; Klaus Eistetter; Ulrich Kilian; Rolf Beume; Hermann Amschler; Uwe Krueger


Archive | 1995

Synthetische peptidanaloge des lungenoberflächenproteins sp-c Synthetic peptide analogue of pulmonary surfactant proteins SP-c

Ruediger Nave; Wolf-Ruediger Ulrich; Ernst Sturm; Uwe Krueger; Dietrich Haefner; P Schaefer; Klaus Melchers


Archive | 1992

NEW ORAL DRUG FORMS

Klemm Kurt; Kurt Klemm; Krueger Uwe; Uwe Krueger; Sturm Ernst; Ernst Sturm; Senn-Bilfinger Joerg; Joerg Senn-Bilfinger

Collaboration


Dive into the Uwe Krueger's collaboration.

Top Co-Authors

Avatar

Kurt Klemm

University of Freiburg

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hermann Amschler

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Klaus Eistetter

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Klaus Melchers

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge